Baird Financial Group, Inc. Shockwave Medical, Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$191.17 - $325.63 $1.45 Million - $2.46 Million	-7,565 Reduced 35.26%	13,891 $4.52 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $974,472 - $1.31 Million	6,053 Added 39.3%	21,456 $4.09 Million
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $227,949 - $333,096	-1,173 Reduced 7.08%	15,403 $3.07 Million
Q2 2023 Aug 11, 2023	BUY	$223.05 - $302.68 $456,583 - $619,585	2,047 Added 14.09%	16,576 $4.73 Million
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $112,086 - $139,250	-639 Reduced 4.21%	14,529 $3.15 Million
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $328,733 - $522,932	-1,684 Reduced 7.59%	20,516 $5.71 Million
Q2 2022 Aug 08, 2022	BUY	$115.91 - $214.48 $138,628 - $256,518	1,196 Added 5.69%	22,200 $4.24 Million
Q1 2022 May 13, 2022	BUY	$127.96 - $207.36 $889,322 - $1.44 Million	6,950 Added 49.45%	21,004 $4.36 Million
Q4 2021 Feb 09, 2022	BUY	$165.13 - $241.83 $165,790 - $242,797	1,004 Added 7.69%	14,054 $2.51 Million
Q3 2021 Nov 12, 2021	BUY	$163.99 - $235.57 $687,118 - $987,038	4,190 Added 47.29%	13,050 $2.69 Million
Q2 2021 Aug 11, 2021	SELL	$131.45 - $201.49 $6,046 - $9,268	-46 Reduced 0.52%	8,860 $1.68 Million
Q1 2021 May 13, 2021	BUY	$92.73 - $142.05 $205,767 - $315,208	2,219 Added 33.18%	8,906 $1.16 Million
Q4 2020 Feb 11, 2021	SELL	$67.44 - $103.72 $185,055 - $284,607	-2,744 Reduced 29.1%	6,687 $694,000
Q3 2020 Nov 12, 2020	BUY	$42.79 - $75.8 $73,598 - $130,376	1,720 Added 22.31%	9,431 $715,000
Q2 2020 Oct 22, 2020	BUY	$27.25 - $47.53 $210,124 - $366,503	7,711 New	7,711 $365,000

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account